BSACI guidelines for the management of chronic urticaria and angio-oedema. - Wikidata - wikimedia - TriplyDB

BSACI guidelines for the management of chronic urticaria and angio-oedema.

BSACI guidelines for the management of chronic urticaria and angio-oedema.

http://www.wikidata.org/entity/Q40220185

about

Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy Histamine H2-receptor antagonists for urticaria The history of the idea of allergy Management of urticaria: not too complicated, not too simple Approaches to the diagnosis and management of chronic urticaria in children The opioid effects of gluten exorphins: asymptomatic celiac disease Anaesthesia-associated hypersensitivity reactions: seven years' data from a British bi-specialty clinic.Increased epidermal filaggrin in chronic idiopathic urticaria is associated with severity of urticaria.Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.Urticaria and angioedema.Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.Pharmacology of antihistamines.Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial Study design and quality of reporting of randomized controlled trials of chronic idiopathic or autoimmune urticaria: review Clinical immunology Vitamin D as a Marker for Disease Severity in Chronic Urticaria and Its Possible Role in Pathogenesis Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria.A stepwise approach in the management of chronic spontaneous urticaria in children.Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.Challenges in the management of chronic urticaria.Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor.Food allergy in adults: an over- or underrated problem?An approach to the patient with urticaria.Chronic urticaria: the autoimmune paradigm.Clinical Immunology Review Series: An approach to the patient with angio-oedema.Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions Clinical evaluation and treatment of chronic urticaria.Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children.Histamine, histamine receptors and antihistamines: new concepts.Chronic spontaneous urticaria in children: itching for insight.Pharmacokinetic evaluation of levocetirizine.Evidence-based evaluation and management of chronic urticaria in children.Chronic urticaria: a comparison of management guidelines.H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?Testing children for allergies: why, how, who and when: an updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI-Clemens von Pirquet Foundation.Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians.Treatment of refractory chronic urticaria: current and future therapeutic options.Allergy in Irish adults: a survey of referrals and outcomes at a major centre.Antihistamine use in children.

P2860

Q21285138-50301A27-33CA-4CBC-A432-1FF00BEC936C Q24201100-2172DA54-F21D-4E8B-B693-40497741E367 Q26826911-E6383D8B-5AFC-479C-9328-7C15C3265264 Q26828373-CE9EF9F0-8A81-472D-AFEB-40A96A059151 Q26852686-912447D6-5545-489D-8BB3-11F4CD65B72D Q28077385-156F477D-80FF-4337-88B0-BF06557F3FE1 Q31023298-672D0F7C-8E94-4506-9BD4-C8D8633B4CCB Q33926863-63DBA33C-EC95-4F6A-8379-485241CA854C Q34194291-660F2834-F7F3-409A-BC7A-FC58C5181F34 Q34215915-367B16E0-1DFD-4ED0-9B3D-E5780B5A742A Q34232188-56F9836D-31B7-4D42-9B79-A42E4B7C4981 Q34347782-AE55F5AC-A0D8-4C20-A9F4-622EFD13A5C2 Q34454209-6321851E-BE9B-411A-91EC-B71BC89F9956 Q34516254-B9FF65F3-6971-4FFC-884A-1E2BE670C4CF Q34935840-BADABB34-A7CB-419B-BC17-CF6CFC50CD1E Q35761768-99316070-E9D9-4E4E-BBB2-9895A9C92F47 Q35931930-8C00F36A-2DE2-43A0-AC99-C6D98C14C840 Q36283580-58E13828-A2BA-4E0D-92D9-608ADF15A5DE Q36516134-A789601A-CA29-43F9-9094-B89AF7F2660F Q36834774-6F79DAE4-FF13-4F7C-8BD5-B8BE83AF2F6A Q36882652-7A1CA99A-395C-4709-B773-BEBDEF305383 Q36925176-7567AD2B-42CA-4077-AA8F-84D8BDAB3CE6 Q37228933-98FA7633-025E-4BFA-9DED-275441E4700B Q37247190-D54DE086-A694-4C81-BD31-5866E94F7CD6 Q37361510-9EF511E5-E7BB-4959-89B0-791A74886D7F Q37394385-A2AB0719-4741-4E3F-8485-FE650D0A1A83 Q37593155-C1E1762C-5424-4158-AD8C-0067B9420FF3 Q37702745-F4F893FB-991D-419D-9B3D-9E34F5947893 Q37702904-C38B4BE6-DE08-4829-B2A2-1F6EC48A8D21 Q37762461-D7583A1A-3C58-46A6-A948-ECE666B23784 Q37831967-738496B7-0FC2-4D09-828A-84E88C4BBA38 Q37884622-2AFF6E50-61B2-4151-A7AD-5C6DB0CB9F79 Q37941747-7E9DFC63-DF77-42F6-8EA5-14B518E7F8BB Q37950484-5F6E05A4-43AE-4E79-A4EA-50A7DD6C1215 Q38044949-735BA510-1671-4040-BA18-10696A38C908 Q38090701-1A5A25A1-03AF-41B0-A6DB-14D8183C4A1A Q38131810-4D31319F-7AE2-4593-BF8E-C77E27CAEC56 Q38148494-0AAF372E-E672-421D-A13B-3DE1413086F5 Q38205411-CB5EC1D4-68C6-4957-A3CE-F9EE417B58CF Q38242172-56CD7473-656E-4D24-BA84-15B7225CAA4D

P2860

BSACI guidelines for the management of chronic urticaria and angio-oedema.

http://www.wikidata.org/entity/Q40220185

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

BSACI guidelines for the management of chronic urticaria and angio-oedema.

@en

type

label

BSACI guidelines for the management of chronic urticaria and angio-oedema.

@en

prefLabel

BSACI guidelines for the management of chronic urticaria and angio-oedema.

@en

P1433

Q40220185-03E9BE97-FC43-48F8-BF09-96A65D77AB4A

P1476

Q40220185-435ED845-E372-4E50-B242-27625F506F2C

P2093

Q40220185-33528F33-FA86-434F-8324-DBF5B398EF64

Q40220185-39FEF459-9C8E-442F-8BC2-C349F03A6025

Q40220185-50E780D8-F91F-4E3E-B40D-ABE1AC240BC1

Q40220185-5D54702D-4DE1-4214-B1DD-77174239AFF7

Q40220185-65899EE2-92CA-42A8-A228-66130C01D692

Q40220185-A048C011-8774-4681-A426-42E86DA76900

Q40220185-A74A0470-FD3A-43F4-8581-7BDE4BF489A5

Q40220185-B1F31803-BF5C-4F97-9A50-9CE15C00E7A1

Q40220185-B285EB04-784E-4022-85C1-7D9E24C38DB4

Q40220185-C8F6A6D1-1D09-4E4D-962E-1C3E63A2B763

P2860

Q40220185-00D7041D-C05E-4729-8FD2-518FE01BFA3A

Q40220185-016F79C8-10A3-4C80-A525-178FE053FD63

Q40220185-017190D2-B9F9-43F6-BCEC-BDED70D7A370

Q40220185-03794933-D844-484C-ACA2-AB5BDC7F976D

Q40220185-03E86F6F-5FEC-462B-94AB-3790EBD06B09

Q40220185-10D120E4-6135-4B21-8EAE-11C154E32027

Q40220185-11F503BB-8C15-4EB4-812A-9AD165661FED

Q40220185-12A82677-C021-44C9-BEE2-F49C208F6AF6

Q40220185-153900C8-22CC-443F-A9C5-F09CA1C2F335

Q40220185-1A68C015-2152-4335-9168-95870AD7C8BB

P304

Q40220185-4FE6C5F4-53AE-4CD6-B04F-DE104258936D

P31

Q40220185-2BE790FC-C6A7-460E-882D-33DB3DA63466

P356

Q40220185-300238EE-BFA8-486C-821A-0EB9D6D48A50

P433

Q40220185-451E94E5-BBD5-49F5-BA11-EFADF6DB041B

P478

Q40220185-481548C0-1695-45B4-8605-4926C0E9ED51

P577

Q40220185-3DD6B4C6-9986-4357-9E4A-62423407D7B0

P5875

Q40220185-27A41CD7-1B3A-4AAB-A877-FEF1137C7292

P698

Q40220185-0D1BCEC1-2B9E-4935-8EA0-6CC277B8225D

P356

J.1365-2222.2007.02678.X

P1433

Clinical & Experimental Allergy

P1476

BSACI guidelines for the management of chronic urticaria and angio-oedema.

@en

P2093

A T Clark

http://www.w3.org/2001/XMLSchema#string

British Society for Allergy and Clinical Immunology (BSACI)

http://www.w3.org/2001/XMLSchema#string

G L Du Toit

http://www.w3.org/2001/XMLSchema#string

N Siddique

http://www.w3.org/2001/XMLSchema#string

P A J Huber

http://www.w3.org/2001/XMLSchema#string

R J Powell

http://www.w3.org/2001/XMLSchema#string

R Mirakian

http://www.w3.org/2001/XMLSchema#string

S C Leech

http://www.w3.org/2001/XMLSchema#string

S M Nasser

http://www.w3.org/2001/XMLSchema#string

S M Walker

http://www.w3.org/2001/XMLSchema#string

P2860

C1 inhibitor deficiency: consensus document

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria

Integration of inflammatory signals by rolling neutrophils.

Urticarial intolerance reaction to cetirizine.

Clinical guidelines: developing guidelines.

Chronic urticaria in childhood.

Drug-induced angioedema without urticaria.

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

P304

631-650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2222.2007.02678.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6373383

http://www.w3.org/2001/XMLSchema#string

P698

17456211

http://www.w3.org/2001/XMLSchema#string